Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cellular components and membranes encompass the essential structural barriers of bacteria, fungi, and parasites, including the cell wall and cytoplasmic membrane (Sarkar et al., 2021, StatPearls). These structures maintain osmotic pressure, provide mechanical strength, and facilitate the transport of ions and nutrients (Silhavy et al., 2010, Cold Spring Harbor Perspectives in Biology). In bacteria, the peptidoglycan layer is a primary target for beta-lactam and glycopeptide antibiotics, which disrupt its synthesis and lead to cell lysis (Bush & Bradford, 2016, Cold Spring Harbor Perspectives in Medicine). Fungal membranes are characterized by the presence of ergosterol, which is targeted by polyene and azole antifungals to compromise membrane integrity or inhibit synthesis (Odds et al., 2003, Journal of Antimicrobial Chemotherapy). Because many of these components are absent in mammalian cells, they provide a basis for selective toxicity in treating infections. However, the broad targeting of these structures can lead to the emergence of resistance and toxicity in the host, such as the nephrotoxicity associated with polymyxins (Poirel et al., 2017, Clinical Microbiology Reviews). Additionally, drugs targeting these components may disrupt the host's commensal microbiome, leading to secondary complications. The diversity of these components across different microbial species necessitates the use of specific agents tailored to the pathogen's unique structural features.
Inhibition of peptidoglycan cross-linking, binding to D-Ala-D-Ala, disruption of membrane phospholipids, and inhibition of ergosterol biosynthesis (Sarkar et al., 2021; Odds et al., 2003).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cellular components and membranes.